US Food and Drug Administration Approval Summary: Imetelstat for Selected Patients With Low- to Intermediate-1 Risk Myelodysplastic Syndromes With Transfusion-Dependent Anemia
美国食品药品监督管理局批准摘要:伊美替司他用于治疗部分低危至中危-1型骨髓增生异常综合征伴输血依赖性贫血患者
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO-25-01369
Kim, Nina; Pulte, E Dianne; Ehrlich, Lori A; Ionan, Alexei C; Haupert, Spencer; Vallejo, Jonathon; Green, Francis; Zheng, Nan; Wang, Yun; Liu, Jiang; Blanco, Javier G; Dorff, Sarah E; Booth, Brian; Choe, Moran; Gehrke, Brenda; Bhatnagar, Vishal; Theoret, Marc; Pazdur, Richard; De Claro, R Angelo; Norsworthy, Kelly J